Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,6213,640 of 20,252 grants

Active NON-SBIR/STTR RPGS
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT Hepatocellular carcinoma (HCC) incidence and mortality is increasing in the US and worldwide. Around ~50- 60% of HCC patients will receive systemic thera...

$4.74M
USD
Active OTHER RESEARCH-RELATED
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2027

Project Summary/Abstract Zimbabwe is a resource-constrained country with a high burden of HIV and cervical cancer (CXCA). Zimbabwean women with CXCA present with advanced disease a...

$2.76M
USD
Completed NON-SBIR/STTR RPGS
Development of a clinically relevant mouse model of lung cancer cachexia to study pathoetiology and therapeutic strategies
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2023 – 2025

PROJECT SUMMARY Cancer cachexia (CC) is characterized by unintentional weight loss secondary to adipose and skeletal muscle tissue wasting. It results from a complex interaction be...

$1.73M
USD
Active NON-SBIR/STTR RPGS
Reprogramming Exosomes for Novel Immunotherapy of Triple Negative Breast Cancer
NATIONAL CANCER INSTITUTE University of Southern California United States 2023 – 2028

Abstract Triple negative breast cancer (TNBC) accounts for approximately 15-20% of breast cancers and is the most aggressive subtype of breast cancer. Given little efficacy for exi...

$4.88M
USD
Active OTHER RESEARCH-RELATED
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2027

Project Summary/Abstract Zimbabwe is a resource-constrained country with a high burden of HIV and cervical cancer (CXCA). Zimbabwean women with CXCA present with advanced disease a...

$5.11M
USD
Active NON-SBIR/STTR RPGS
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT Hepatocellular carcinoma (HCC) incidence and mortality is increasing in the US and worldwide. Around ~50- 60% of HCC patients will receive systemic thera...

$4.56M
USD
Active TRAINING, INDIVIDUAL
The role of tumor cell-of-origin-specific PDL1 on tumorigenesis and tumor progression
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2023 – 2027

ABSTRACT This F31-diversity proposal investigates the role of PDL1 in early melanoma progression using our novel cancer cell-of-origin autochthonous mouse model. Our overarching hy...

$390.1K
USD
Active OTHER RESEARCH-RELATED
A systems biology approach to elucidate the biology of immune-associated outcomes in breast cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

PROJECT SUMMARY This K01 application seeks protected time for mentored research and career development training for Dr. Rosalyn Sayaman, PhD to successfully transition to tenure-tr...

$1.74M
USD
Completed TRAINING, INDIVIDUAL
Defining a novel subset of metastasis-associated monocytes
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2025

Project Summary/Abstract Metastasis is a feature of advanced disease whereby tumor cells spread to distant parts of the body, and is responsible for the vast majority of cancer-rel...

$459.1K
USD
Active RESEARCH CENTERS
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – OVERALL The partnership center, entitled Partnership to Assess Viral and Immune Landscape Intersections with Oncology (PAVILION) for People Living with HIV Progra...

$12.45M
USD
Active RESEARCH CENTERS
Administration & Coordinating Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – ADMINISTRATIVE & COORDINATING CORE The Administrative & Coordinating (AC) Core for the Partnership to Assess Viral and Immune Landscape Intersections with...

Active RESEARCH CENTERS
Project 1: Exploring viral and immunological factors of HPV associated cancers in PLWH and its relation to survival
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – PROJECT 1 People living with HIV (PLWH) have significantly higher cancer incidence compared to people without HIV for cancers caused by HPV (cervical, vulvar, ana...

Active RESEARCH CENTERS
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – PROJECT 2 Conjunctival squamous cell carcinoma (cSCC) is an eye cancer with unknown etiology. cSCC disproportionately impacts Sub-Saharan Africa (SSA), a setting...

Active RESEARCH CENTERS
Data Management & Statistical Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – DATA MANAGEMENT & STATISTICS CORE The overarching goal of the Data Management & Statistics Core (DMSC) for the Partnership to Assess Viral and Immune Land...

Active RESEARCH CENTERS
Central Laboratory Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – CENTRAL LABORATORY CORE The overarching goal of the Central Laboratory (CL) Core for the Partnership to Assess Viral and Immune Landscape Intersections with Oncol...

Active RESEARCH CENTERS
Developmental & Career Enhancement Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2028

PROJECT SUMMARY – DEVELOPMENTAL CORE The overarching goal of the Developmental Core (DC) for the Partnership to Assess Viral and Immune Landscape Intersections with Oncology for Pe...

Completed OTHER RESEARCH-RELATED
Molecular dissection of extrachromosomal DNA formation, development, and evolution
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2025

PROJECT SUMMARY / ABSTRACT The devastation wrought by cancer derives primarily from the capacity of tumor cells to evolve. Metastasis, immune evasion, treatment resistance, and eve...

$1.26M
USD
Active OTHER RESEARCH-RELATED
A systems biology approach to elucidate the biology of immune-associated outcomes in breast cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

PROJECT SUMMARY This K01 application seeks protected time for mentored research and career development training for Dr. Rosalyn Sayaman, PhD to successfully transition to tenure-tr...

$1.73M
USD
Active TRAINING, INDIVIDUAL
The role of tumor cell-of-origin-specific PDL1 on tumorigenesis and tumor progression
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2023 – 2027

ABSTRACT This F31-diversity proposal investigates the role of PDL1 in early melanoma progression using our novel cancer cell-of-origin autochthonous mouse model. Our overarching hy...

$377.3K
USD
Active NON-SBIR/STTR RPGS
Randomized clinical trial to test the efficacy of a smartphone app for smoking cessation for nondaily smokers
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

Project Summary Nondaily smoking is an increasingly prevalent pattern of smoking with substantial health detriments. Currently, 25% of all U.S. adult smokers are nondaily smokers,...

$7.07M
USD